ATX Trademark

Trademark Overview

On Thursday, November 9, 2023, a trademark application was filed for ATX with the United States Patent and Trademark Office. The USPTO has given the ATX trademark a serial number of 79386489. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, February 6, 2025. This trademark is owned by AlgoTherapeutix. The ATX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical products; veterinary products; chemical preparations for medical use; pharmaceutical preparations; chemico-pharmaceutical products; pharmaceutical substances; medicines; pharmaceutical solutions; diagnostic agents for medical use; chemical products for pharmaceutical use; chemical reagents for medical use; chemical reagents for veterinary use; chemical preparations for medical use; chemical preparations for pharmaceutical use; chemical analysis reagents for medical use; chemical analysis reagents for veterinary use; pharmaceuticals for the treatment of rare diseases; all these products being intended for use in the treatment of complex pain

Scientific and technical research services; technical project studies; scientific laboratory services; carrying out clinical trials for pharmaceutical products; provision of information concerning the results of clinical trials for pharmaceutical products; provision of information in connection with medical and scientific research in the field of pharmaceutical products and clinical trials; biological, clinical and medical research; clinical research; carrying out clinical trials; research in the field of medicines; development of pharmaceutical preparations and medicines; research and development of medicines; research and development of pharmaceutical products; laboratory research services concerning pharmaceutical products; consultancy with respect to pharmaceutical research and development; consulting relating to pharmacology; consultancy in the field of pharmaceutical research; services for conducting early assessments of new pharmaceuticals; all these services being intended to b...
atx

General Information

Serial Number79386489
Word MarkATX
Filing DateThursday, November 9, 2023
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, February 6, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical products; veterinary products; chemical preparations for medical use; pharmaceutical preparations; chemico-pharmaceutical products; pharmaceutical substances; medicines; pharmaceutical solutions; diagnostic agents for medical use; chemical products for pharmaceutical use; chemical reagents for medical use; chemical reagents for veterinary use; chemical preparations for medical use; chemical preparations for pharmaceutical use; chemical analysis reagents for medical use; chemical analysis reagents for veterinary use; pharmaceuticals for the treatment of rare diseases; all these products being intended for use in the treatment of complex pain
Goods and ServicesScientific and technical research services; technical project studies; scientific laboratory services; carrying out clinical trials for pharmaceutical products; provision of information concerning the results of clinical trials for pharmaceutical products; provision of information in connection with medical and scientific research in the field of pharmaceutical products and clinical trials; biological, clinical and medical research; clinical research; carrying out clinical trials; research in the field of medicines; development of pharmaceutical preparations and medicines; research and development of medicines; research and development of pharmaceutical products; laboratory research services concerning pharmaceutical products; consultancy with respect to pharmaceutical research and development; consulting relating to pharmacology; consultancy in the field of pharmaceutical research; services for conducting early assessments of new pharmaceuticals; all these services being intended to be offered for the treatment of complex pain

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 29, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 29, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAlgoTherapeutix
Party Type10 - Original Applicant
Legal Entity Type34 - NOT AVAILABLE
AddressFR

Trademark Events

Event DateEvent Description
Friday, December 29, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 2, 2024APPLICATION FILING RECEIPT MAILED
Thursday, June 27, 2024NON-FINAL ACTION WRITTEN
Thursday, December 28, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, June 17, 2024ASSIGNED TO EXAMINER
Friday, June 28, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, July 23, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, August 11, 2024REFUSAL PROCESSED BY IB
Friday, August 16, 2024ASSIGNED TO EXAMINER
Thursday, February 6, 2025ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, May 27, 2025NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, May 27, 2025NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Friday, June 13, 2025NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Thursday, February 6, 2025ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, July 23, 2024REFUSAL PROCESSED BY MPU

Related Keywords

pharmaceutical products research chemical medical clinical services preparations reagents trials